Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2026)

Krystal Biotech has reported Exchange Rate Effect for 5 years, with the latest figure at -$1.8 million in Q2 2026.

• Exchange Rate Effect for Q2 2026 came in at -$1.8 million, down 272.9% year-over-year; the trailing twelve-month figure through Jun 2026 was -$4.1 million (down 545.34% YoY), and the FY2025 annual result was $286000.0, up 162.45% from the prior year.
• Exchange Rate Effect retreated to -$1.8 million in Q2 2026, from -$1.3 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $1.1 million in Q2 2025 and troughed at -$1.8 million in Q2 2026.
• A 5-year average of -$235400.0 and a median of -$41000.0 in 2022 frame the typical range for Exchange Rate Effect.
• The largest YoY upside for Exchange Rate Effect was 2283.33% in 2024 against a maximum downside of 4312.5% in 2024.
• A 5-year view of Exchange Rate Effect shows it stood at -$41000.0 in 2022, then slumped by 241.46% to -$140000.0 in 2023, then tumbled by 324.29% to -$594000.0 in 2024, then declined by 7.24% to -$637000.0 in 2025, then tumbled by 187.44% to -$1.8 million in 2026.
• Per Business Quant data, the three most recent Exchange Rate Effect figures were -$1.8 million in Q2 2026, -$1.3 million in Q1 2026, and -$637000.0 in Q4 2025.